Date: Tue 15/09/2020 - Tue 15/09/2020
Provider: Glaukos
Optometrist Credits: 1 Clinical Diagnostic Credit
Event Type(s): Online
Contact
Email: mkittikhoun@glaukos.com
Number: +61 447067699
URL: https://glaukos.zoom.us/webinar/register/WN_enhkDLV4TdqUOD_YfCVThQ
Learning objectives:
Session 1 (25 min lecture)
Glaucoma is incurable, however, early intervention can delay or stop the progression of the disease. Treatment is focused on lowering IOP typically begins with eye drops. Glaucoma medications are a burden to patients and can have side effects on the ocular surface and leads to non-compliance.
The objective of session one is to discuss ocular surface disease as a result of glaucoma medications and early interventions, including Micro Bypass Glaucoma Surgery (MBGS), that are available to lower IOP, reduce medication burden and improve ocular surface health.
Session 2 (25 min lecture)
Keratoconus, often referred to as ‘KC’, is a non-inflammatory eye condition in which the the cornea progressively thins and weakens, causing the development of a cone-like bulge and irregular astigmatism. Keratoconus can result in significant vision loss; and may lead to corneal transplant in severe cases.
The objective of session two is to look at the safety and effectiveness of corneal crosslinking and benefits of early diagnosis and intervention with corneal crosslinking in preserving patient’s vision and quality of life
This will be followed by questions & discussion (10min)